RNA-Targeted Drug Discovery Summit returns for its fifth year this December. Join the summit for deep dive into new and emerging topics such as:

• Induced Proximity as a new class of “targeted RNA degraders”
• Next-generation probing and screening technologies to accelerate HIT identification and validation
• Biophysical, biochemical, and cell-based assay development strategies to identify and optimize small molecules interacting with RNA
• In vivo pharmacology, safety, and efficacy early considerations to accelerate the transition from discovery to pre-clinical and clinical development

View the event program here: https://ter.li/7qs017

Secure your place here: https://ter.li/jlh128

If you have any further questions regarding the summit, please contact us at info@hansonwade.com.